Citations (170)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Valentina Elisabetta Bounous, Silvia Actis, Roberta Rosso, Margherita Giorgi, Lara Tiranini, Rossella Elena Nappi & Nicoletta Biglia. (2023) No-daily hormonal contraception today: general overview and application in specific clinical settings. Gynecological Endocrinology 39:1.
Read now
Read now
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Read now
Luis Bahamondes. (2022) Awareness of the non-contraceptive benefits of reversible contraceptive methods in a cohort of Brazilian women: an exploratory study. The European Journal of Contraception & Reproductive Health Care 27:4, pages 294-299.
Read now
Read now
Kristin Ambacher, Michael Secter & Ari P. Sanders. (2022) The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review. Current Medical Research and Opinion 38:3, pages 479-486.
Read now
Read now
Lekai Nie, Hongli Zou, Xiaotian Ma, Lei Cheng, Jun Jiao, Fenghua Wang, Weifeng Liang & Peihai Zhang. (2021) A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients. Gynecological Endocrinology 37:8, pages 735-739.
Read now
Read now
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, Christoph Gerlinger & Tim Friede. (2021) Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems. The European Journal of Contraception & Reproductive Health Care 26:1, pages 48-57.
Read now
Read now
Andrea M. Peterson, Amy Brown, Ashlyn Savage & Angela Dempsey. (2019) Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. The European Journal of Contraception & Reproductive Health Care 24:6, pages 475-479.
Read now
Read now
Manuel Lozano, María Antonia Obiol, Juanjo Peiró & José María Ramada. (2019) Effect of cost on early removal of contraceptive implants: a prospective cohort study. The European Journal of Contraception & Reproductive Health Care 24:1, pages 24-29.
Read now
Read now
Esther López del Cerro, Carolina Serrano Diana, Ana María Castillo Cañadas, Esteban González Mirasol, Francisco García Santos, María Teresa Gómez García & Gaspar González de Merlo. (2018) Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants. Journal of Obstetrics and Gynaecology 38:7, pages 979-984.
Read now
Read now
Jennifer Villavicencio & Rebecca H Allen. (2016) Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates. Open Access Journal of Contraception 7, pages 43-52.
Read now
Read now
Melody Y. Hou, Colleen McNicholas & Mitchell D. Creinin. (2016) Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial. The European Journal of Contraception & Reproductive Health Care 21:5, pages 361-366.
Read now
Read now
Conrado S. Ragazini, Maria Valeria Bahamondes, Tatiana R. Rocha Prandini, Milena Bastos Brito, Eliana Amaral, Luis Bahamondes, Geraldo Duarte, Silvana Maria Quintana, Rui Alberto Ferriani & Carolina Sales Vieira. (2016) Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy. The European Journal of Contraception & Reproductive Health Care 21:4, pages 285-289.
Read now
Read now
Edith Weisberg & Ian S Fraser. (2015) Contraception and endometriosis: challenges, efficacy, and therapeutic importance. Open Access Journal of Contraception 6, pages 105-115.
Read now
Read now
Costantino Di Carlo, Maurizio Guida, Nicoletta De Rosa, Anna Sansone, Virginia Gargano, Angelo Cagnacci & Carmine Nappi. (2015) Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population. Gynecological Endocrinology 31:6, pages 491-494.
Read now
Read now
Sam Rowlands & Stephen Searle. (2014) Contraceptive implants: current perspectives. Open Access Journal of Contraception 5, pages 73-84.
Read now
Read now
Anna Maria Teunissen, Bernd Grimm & Frans J. M. E. Roumen. (2014) Continuation rates of the subdermal contraceptive Implanon® and associated influencing factors. The European Journal of Contraception & Reproductive Health Care 19:1, pages 15-21.
Read now
Read now
Edith Weisberg. (2014) Developments in contraception. Expert Opinion on Pharmacotherapy 15:2, pages 203-210.
Read now
Read now
Jaclyn Grentzer, Colleen McNicholas & Jeffrey F Peipert. (2013) Use of the etonogestrel-releasing contraceptive implant. Expert Review of Obstetrics & Gynecology 8:4, pages 337-344.
Read now
Read now
Mohamed Laban, Magda Abd Alhamid, Eman A. Ibrahim, Ali Elyan & Ahlam Ibrahim. (2012) Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt. The European Journal of Contraception & Reproductive Health Care 17:6, pages 451-457.
Read now
Read now
Stefano Palomba, Angela Falbo, Annalisa Di Cello, Caterina Materazzo & Fulvio Zullo. (2012) Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecological Endocrinology 28:9, pages 710-721.
Read now
Read now
Semara Thomas & Joseph Sanfilippo. (2011) Managing the reproductive health of pediatric and adolescent patients. Expert Review of Obstetrics & Gynecology 6:6, pages 655-666.
Read now
Read now
Flora Bacopoulou, Donald E. Greydanus & George P. Chrousos. (2010) Reproductive and contraceptive issues in chronically ill adolescents. The European Journal of Contraception & Reproductive Health Care 15:6, pages 389-404.
Read now
Read now
Lisa Vicente, Denisa Mendonça, Marina Dingle, Rui Duarte & J. Manuel Boavida. (2008) Etonogestrel implant in women with diabetes mellitus. The European Journal of Contraception & Reproductive Health Care 13:4, pages 387-395.
Read now
Read now
Articles from other publishers (147)
K. Kolanska, L. Duranteau, M. Bazot, E. Daraï & N. Chabbert-Buffet. (2023) Menometrorragie al di fuori della gravidanza. EMC - Urgenze 27:4, pages 1-11.
Crossref
Crossref
M.Y. Bongers, T Oderkerk, M Herman & P.M.A.J. Geomini. (2023) Nonsurgical treatment options for heavy menstrual bleeding. Facts, Views and Vision in ObGyn 15:Monograph, pages 17-23.
Crossref
Crossref
J.L. Brun, G. Plu-Bureau, C. Huchon, X. Ah-Kit, M. Barral, P. Chauvet, F. Cornelis, M. Cortet, P. Crochet, V. Delporte, G. Dubernard, G. Giraudet, A. Gosset, O. Graesslin, J. Hugon-Rodin, L. Lecointre, G. Legendre, L. Maitrot-Mantelet, L. Marcellin, L. Miquel, M. Le Mitouard, C. Proust, A. Roquette, P. Rousset, E. Sangnier, M. Sapoval, T. Thubert, A. Torre, F. Trémollières, H. Vernhet-Kovacsik, F. Vidal & H. Marret. (2023) Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF). European Journal of Obstetrics & Gynecology and Reproductive Biology 288, pages 90-107.
Crossref
Crossref
Mohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, Suyash Deodhar, Srijanee Das, Ashrafi Sultana, Nam Thai Hoang Le, Vicente Soriano, Benson Edagwa & Howard E. Gendelman. (2023) Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. Advanced Drug Delivery Reviews 200, pages 115009.
Crossref
Crossref
Chelsey A. Harris, Rachel S. Mandelbaum, Alesandra R. Rau, Bonnie B. Song, Maximilian Klar, Joseph G. Ouzounian, Richard J. Paulson, Lynda D. Roman & Koji Matsuo. (2023) Contraception and sterilization selection at delivery among pregnant patients with malignancy. Acta Obstetricia et Gynecologica Scandinavica.
Crossref
Crossref
Alison Edelman, Emily Boniface, Kaitlin Schrote, Marci Messerle-Forbes, Andrea O’Donnell, Jeffrey T. Jensen & Leo Han. (2023) Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin. American Journal of Obstetrics and Gynecology 229:2, pages 145.e1-145.e9.
Crossref
Crossref
J.D. Zuheros Montes, Y. Nieto Espinar & M.C. Zuheros Montes. (2023) Estudio descriptivo sobre la satisfacción de las usuarias de Implanon® y los motivos para su retirada. Clínica e Investigación en Ginecología y Obstetricia 50:2, pages 100825.
Crossref
Crossref
Beatriz Ferro, Mafalda Simões, Bárbara Gomes, Ângela Rodrigues, Fernanda Geraldes & Fernanda Águas. (2023) Contraceção Reversível de Longa Duração na Adolescência: A Realidade de um Hospital Pediátrico Terciário em Portugal. Acta Médica Portuguesa.
Crossref
Crossref
Susan Walker, Leica Claydon‐Mueller, Russell Kabir, Hilary Piercy, Marie‐Therese Massey & Italo Costanzo. (2023) Systematic review of factors predictive of unfavourable vaginal bleeding in women of reproductive age using the contraceptive etonogestrel implant. Reproductive, Female and Child Health.
Crossref
Crossref
A. Martínez Pérez, J. Terrón Barroso, N. Alayón Hernández & N.E. Ariza Chana. (2023) Métodos anticonceptivos de larga duración (LARC): características de las usuarias, tasa de continuidad y efectividad. Clínica e Investigación en Ginecología y Obstetricia 50:1, pages 100800.
Crossref
Crossref
Megen Vo. 2023. Encyclopedia of Child and Adolescent Health. Encyclopedia of Child and Adolescent Health
965
972
.
Kirsty Moore. (2023) Choice and use of long‐acting reversible contraceptives. Prescriber 34:1, pages 9-15.
Crossref
Crossref
Serena Liu, Olga Kciuk, Madelyn Frank & Nichole Tyson. (2022) Progestins of today and tomorrow. Current Opinion in Obstetrics & Gynecology 34:6, pages 344-350.
Crossref
Crossref
Mitchell D. Creinin. (2022) ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression. Obstetrics & Gynecology 140:6, pages 1079-1080.
Crossref
Crossref
Bolarinwa T. Olaifa, Henry I. Okonta, Justin B. Mpinda & Indiran Govender. (2022) Reasons given by women for discontinuing the use of progestogen implants at Koster Hospital, North West province. South African Family Practice 64:1.
Crossref
Crossref
Courtney C. Baker & Mitchell D. Creinin. (2022) Long-Acting Reversible Contraception. Obstetrics & Gynecology 140:5, pages 883-897.
Crossref
Crossref
Natalia V. Aganezova & Sergey S. Aganezov. (2022) Prolonged hormonal contraception: current research and practice: A review. Gynecology 24:4, pages 252-260.
Crossref
Crossref
Sérgio Henrique Pires Okano, Giovanna Giulia Milan Pellicciotta & Giordana Campos Braga. (2022) Contraceptive Counseling for the Transgender Patient Assigned Female at Birth. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 44:09, pages 884-890.
Crossref
Crossref
Jarbas Magalhaes, Edson Santos Ferreira-Filho, Jose Maria Soares-Junior & Edmund Chada Baracat. (2022) Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up. European Journal of Obstetrics & Gynecology and Reproductive Biology 276, pages 56-62.
Crossref
Crossref
Gemechu Nigusie Beyene, Nega Assefa, Taklu Marama Mokonnon, Habtamu Bekele Ejigu & Tesfaye Assebe Yadeta. (2022) Early Implanon discontinuation and associated factors among Implanon women users visiting public health facilities, in Kembata zone of Southern Ethiopia: An institution based cross-sectional study. Frontiers in Global Women's Health 3.
Crossref
Crossref
Mitchell D. Creinin, Carolina Sales Vieira, Carolyn L. Westhoff & Diana J.A. Mansour. (2022) Recommendations for standardization of bleeding data analyses in contraceptive studies. Contraception 112, pages 14-22.
Crossref
Crossref
Lou Donval, Nina Oufkir, Dorian Bondu, Eric Daoud, Elise Dumas, Fabien Reyal & Anne-Sophie Hamy. (2022) Évolution des pratiques contraceptives en France : un état des lieux de 2014 à 2019. Gynécologie Obstétrique Fertilité & Sénologie 50:7-8, pages 535-541.
Crossref
Crossref
Julie C. Friedman, Eliza Buyers, Jaime Laurin, Karen Hampanda & Veronica I. Alaniz. (2022) Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice. Journal of Pediatric and Adolescent Gynecology 35:3, pages 341-345.
Crossref
Crossref
J.-L. Brun, G. Plu-Bureau, C. Huchon, X. Ah-Kit, M. Barral, P. Chauvet, F. Cornelis, M. Cortet, P. Crochet, V. Delporte, G. Dubernard, G. Giraudet, A. Gosset, O. Graesslin, J. Hugon-Rodin, L. Lecointre, G. Legendre, L. Maitrot-Mantelet, L. Marcellin, L. Miquel, M. Le Mitouard, C. Proust, A. Roquette, P. Rousset, E. Sangnier, M. Sapoval, T. Thubert, A. Torre, F. Trémollières, H. Vernhet-Kovacsik, F. Vidal & H. Marret. (2022) Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF). Gynécologie Obstétrique Fertilité & Sénologie 50:5, pages 345-373.
Crossref
Crossref
Johannes Bitzer. 2022. Handbook of Contraception and Sexual Reproductive Healthcare. Handbook of Contraception and Sexual Reproductive Healthcare
43
55
.
Shandhini Raidoo, Marit Pearlman Shapiro & Bliss Kaneshiro. (2021) Contraception in Adolescents. Seminars in Reproductive Medicine 40:01/02, pages 089-097.
Crossref
Crossref
Ana Jacinto, Adalgisa Viola Ronda, Connie Lee, Fariyal F. Fikree & Eric Ramirez-Ferrero. (2022) Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care. Global Health: Science and Practice 10:1, pages e2100252.
Crossref
Crossref
Le‐Kai Nie, Hong‐Li Zou, Lei Cheng & Pei‐Hai Zhang. (2021) Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports. Journal of Obstetrics and Gynaecology Research 48:1, pages 262-265.
Crossref
Crossref
Stephanie Teal & Alison Edelman. (2021) Contraception Selection, Effectiveness, and Adverse Effects. JAMA 326:24, pages 2507.
Crossref
Crossref
Sarah Green, Jeanelle Sheeder & Molly Richards. (2021) The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion. Journal of Pediatric and Adolescent Gynecology 34:6, pages 825-831.
Crossref
Crossref
Jacqueline Ding, Henrietta Williams, Jane S. Hocking & Jacqueline Coombe. (2021) Requesting early removal of long-acting reversible contraception: a qualitative study exploring the experiences of doctors working in primary care. Australian Journal of Primary Health 27:6, pages 467-472.
Crossref
Crossref
Ilaria Mancini, Stefania Alvisi, Giulia Gava, Renato Seracchioli & Maria Cristina Meriggiola. (2021) Contraception across transgender. International Journal of Impotence Research 33:7, pages 710-719.
Crossref
Crossref
Jessica Lew, Jeanelle Sheeder & Aaron Lazorwitz. (2021) Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients. Contraception 104:5, pages 556-560.
Crossref
Crossref
Vivian Brache, Carolina Sales Vieira, Marlena Plagianos, Maud Lansiaux, Ruth Merkatz, Heather Sussman, Leila Cochon, Ana S Tejada, Narender Kumar, Daniel Loeven, Diana L Blithe, Abi Santhosh Aprem, Alistair RW Williams, Athilakshmi Kannan, Indrani C Bagchi & Regine Sitruk-Ware. (2021) Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. Contraception 104:4, pages 327-336.
Crossref
Crossref
Aaron Lazorwitz, Christina L. Aquilante, Jonathan A. Shortt, Jeanelle Sheeder, Stephanie Teal & Christopher R. Gignoux. (2021) Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception. Clinical and Translational Science 14:5, pages 1713-1718.
Crossref
Crossref
Y. Frances Fei, Susan D. Ernst, Melina L. Dendrinos & Elisabeth H. Quint. (2021) Satisfaction With Hormonal Treatment for Menstrual Suppression in Adolescents and Young Women With Disabilities. Journal of Adolescent Health 69:3, pages 482-488.
Crossref
Crossref
Sai Archana Krovi, Leah M. Johnson, Ellen Luecke, Sharon L. Achilles & Ariane van der Straten. (2021) Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention. Advanced Drug Delivery Reviews 176, pages 113849.
Crossref
Crossref
Toeresin Karakoyun, Hans-Peter Podhaisky, Ann-Kathrin Frenz, Gabriele Schuhmann-Giampieri, Thais Ushikusa, Daniel Schröder, Michal Zvolanek & Agnaldo Lopes Da Silva Filho. (2021) Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development Study. JMIR Medical Informatics 9:7, pages e24633.
Crossref
Crossref
Bethany Samuelson Bannow, Claire McLintock & Paula James. (2021) Menstruation, anticoagulation, and contraception: VTE and uterine bleeding. Research and Practice in Thrombosis and Haemostasis 5:5, pages e12570.
Crossref
Crossref
Kathryn J. Lindley, C. Noel Bairey Merz, Melinda B. Davis, Tessa Madden, Ki Park & Natalie A. Bello. (2021) Contraception and Reproductive Planning for Women With Cardiovascular Disease. Journal of the American College of Cardiology 77:14, pages 1823-1834.
Crossref
Crossref
Leanne R. McCloskeyKatherine L. WisnerMinaz Kolia CattanHannah K. BetcherCatherine S. StikaJessica W. Kiley. (2021) Contraception for Women With Psychiatric Disorders. American Journal of Psychiatry 178:3, pages 247-255.
Crossref
Crossref
. (2021) FSRH Guideline (February 2021) Progestogen-only Implant. BMJ Sexual & Reproductive Health 47:Suppl 1, pages 1-62.
Crossref
Crossref
Li LiDoanh TranHao ZhuPraveen BalimaneGerald Willett, Ping Zhao, Stephen E. Gerrard, Kirsten M. Vogelsong, Yaning WangShirley K. Seo. (2021) Use of Model-Informed Drug Development to Streamline Development of Long-Acting Products: Can These Successes Be Translated to Long-Acting Hormonal Contraceptives?. Annual Review of Pharmacology and Toxicology 61:1, pages 745-756.
Crossref
Crossref
Christiane Borges do Nascimento Chofakian, Osmara Alves Viana, Eveline do Amor Divino & Ana Luiza Vilela Borges. (2021) Dinâmica contraceptiva antes e após o uso da anticoncepção de emergência: descontinuidades contraceptivas e bridging. Cadernos de Saúde Pública 37:12.
Crossref
Crossref
Xiaocen Niu, Qun Luo, Chunfen Wang, Lihua Zhu & Lili Huang. (2021) Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis. Medicine 100:6, pages e24597.
Crossref
Crossref
Federica Visconti & Costantino Di Carlo. 2021. Endometriosis Pathogenesis, Clinical Impact and Management. Endometriosis Pathogenesis, Clinical Impact and Management
65
71
.
Karen L. Florio, Monica Kao, Traci Johnson, Heidi A. Tuttle, Darcy White, Lynne Nelson, Neil Patel, Devon Ramaeker, Sue Kendig, Laura Schmidt, Anna Grodzinsky & Katherine Economy. (2020) Contraception for the Cardiac Patient: a Cardiologist’s Primer. Current Treatment Options in Cardiovascular Medicine 22:12.
Crossref
Crossref
Leonidas Panagiotakopoulos, Veenod Chulani, Atsuko Koyama, Krista Childress, Michelle Forcier, Gwen Grimsby & Katherine Greenberg. (2020) The effect of early puberty suppression on treatment options and outcomes in transgender patients. Nature Reviews Urology 17:11, pages 626-636.
Crossref
Crossref
Elise D. Berlan, Molly J. Richards, Carolina Sales Vieira, Mitchell D. Creinin, Andrew M. Kaunitz, Ian S. Fraser, Alison Edelman & Diana Mansour. (2020) Best Practices for Counseling Adolescents about the Etonogestrel Implant. Journal of Pediatric and Adolescent Gynecology 33:5, pages 448-454.
Crossref
Crossref
Melissa A. Parks, Noor Zwayne & M'hamed Temkit. (2020) Bleeding Patterns among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review. Journal of Pediatric and Adolescent Gynecology 33:5, pages 555-558.
Crossref
Crossref
YASMIN Z. BAHAR & MELANIE A. GOLD. (2020) Providing Long-acting Reversible Contraception to Adolescents: A Review. Clinical Obstetrics & Gynecology 63:3, pages 561-573.
Crossref
Crossref
Alison B. Edelman, Bliss Kaneshiro, Katharine B. Simmons, Jennifer L. Hauschildt, Kise Bond, Emily R. Boniface & Jeffrey T. Jensen. (2020) Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users. Obstetrics & Gynecology 136:2, pages 323-332.
Crossref
Crossref
P. Z. Akilimali, Hernandez J.Anglewicz P.Kayembe K. P.Bertrand J.. (2020) Incidence and determinants of Implanon discontinuation: Findings from a prospective cohort study in three health zones in Kinshasa, DRC. PLOS ONE 15:5, pages e0232582.
Crossref
Crossref
Siti N. Upawi, Mohd F. Ahmad, Muhammad A. Abu & Shuhaila Ahmad. (2020) Management of bleeding irregularities among etonogestrel implant users: Is combined oral contraceptives pills or nonsteroidal anti‐inflammatory drugs the better option?. Journal of Obstetrics and Gynaecology Research 46:3, pages 479-484.
Crossref
Crossref
Chance Krempasky, Miles Harris, Lauren Abern & Frances Grimstad. (2020) Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology 222:2, pages 134-143.
Crossref
Crossref
Milena Bastos Brito. (2020) Contraceptive satisfaction among women with sickle cell anemia. International Journal of Pregnancy & Child Birth 6:1, pages 1-4.
Crossref
Crossref
George Odwe, Francis Obare, Kazuyo Machiyama & John Cleland. (2020) Which contraceptive side effects matter most? Evidence from current and past users of injectables and implants in Western Kenya. Contraception: X 2, pages 100030.
Crossref
Crossref
Krishna Gautam, Shreya Dwivedi, Dhirendra Singh & Sadasivam Anbumani. 2020. Toxicological Aspects of Medical Device Implants. Toxicological Aspects of Medical Device Implants
135
157
.
Jeffrey P. Levine & Joshua A. Mleczko. 2020. Primary Care Procedures in Women's Health. Primary Care Procedures in Women's Health
175
198
.
Elizabeth Schmidt, Sarah L. Pachtman & Justin T. Diedrich. 2020. Obstetric and Gynecologic Nephrology. Obstetric and Gynecologic Nephrology
225
243
.
Tsirity G/Medhin, Kahsu Gebrekirstos Gebrekidan, Mekuria Kassa Nerea, Hagos Gerezgiher & Mebrahtom Haftu. (2019) Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016/17. BMC Research Notes 12:1.
Crossref
Crossref
Christiane Borges do Nascimento Chofakian, Caroline Moreau, Ana Luiza Vilela Borges & Osmara Alves dos Santos. (2019) Contraceptive discontinuation: frequency and associated factors among undergraduate women in Brazil. Reproductive Health 16:1.
Crossref
Crossref
Joshua Dean, Katherine J. Kramer, Fauzia Akbary, Shaunte Wade, Maik Hüttemann, Jay M. Berman & Maurice-Andre Recanati. (2019) Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial. BMC Women's Health 19:1.
Crossref
Crossref
Carolina Sales Vieira, Ian S. Fraser, Marlena G Plagianos, Anne E. Burke, Carolyn L. Westhoff, Jeffrey Jensen, Vivian Brache, Luis Bahamondes, Ruth Merkatz, Regine Sitruk-Ware & Diana L. Blithe. (2019) Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials. Contraception 100:6, pages 438-444.
Crossref
Crossref
Aaron Lazorwitz, Christina L. Aquilante, Eva Dindinger, Margaret Harrison, Jeanelle Sheeder & Stephanie Teal. (2019) Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. Obstetrics & Gynecology 134:4, pages 807-813.
Crossref
Crossref
Diana Mansour, Ian S. Fraser, Alison Edelman, Carolina S. Vieira, Andrew M. Kaunitz, Tjeerd Korver, Annpey Pong, Jianxin Lin, Arvind K. Shah, Michelle Fox, Hans Rekers & Mitchell D. Creinin. (2019) Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?. Contraception 100:4, pages 264-268.
Crossref
Crossref
Carolina Sales Vieira, Mariane Nunes de Nadai, Lilian Sheila de Melo Pereira do Carmo, Giordana Campos Braga, Bruna Fregonesi Infante, Bianca M Stifani, Rui Alberto Ferriani & Silvana Maria Quintana. (2019) Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception 100:4, pages 258-263.
Crossref
Crossref
Lisa M. Goldthwaite & Mitchell D. Creinin. (2019) Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems. Contraception 100:2, pages 128-131.
Crossref
Crossref
Carolina Sales Vieira, Alison Pack, Kevin Roberts & Anne R. Davis. (2019) A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs. Contraception 99:4, pages 251-255.
Crossref
Crossref
Yusuke Ueda, Chizuko A. Kamiya, Chinami Horiuchi, Takekazu Miyoshi, Ryoichi Hazama, Mitsuhiro Tsuritani, Naoko Iwanaga, Reiko Neki, Tomoaki Ikeda & Jun Yoshimatsu. (2018) Safety and efficacy of a 52‐mg levonorgestrel‐releasing intrauterine system in women with cardiovascular disease. Journal of Obstetrics and Gynaecology Research 45:2, pages 382-388.
Crossref
Crossref
Lisa A. Rubinsak, Mindy S. Christianson, Aletha Akers, Jeanne Carter, Andrew M. Kaunitz & Sarah M. Temkin. (2018) Reproductive health care across the lifecourse of the female cancer patient. Supportive Care in Cancer 27:1, pages 23-32.
Crossref
Crossref
Chelsea B. Polis, Rubina Hussain & Amanda Berry. (2018) There might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes. Reproductive Health 15:1.
Crossref
Crossref
L. Amat, A. Bulach, M. Leclercq, S. Mesrine, F. Scheffler, D. Sperandeo & M. Scheffler. (2018) Bénéfices non contraceptifs des contraceptions. RPC Contraception CNGOF. Gynécologie Obstétrique Fertilité & Sénologie 46:12, pages 883-888.
Crossref
Crossref
Khalida Itriyeva. (2018) Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents. Current Problems in Pediatric and Adolescent Health Care 48:12, pages 321-332.
Crossref
Crossref
Rachel E. Zigler, Tessa Madden, Caitlin Ashby, Leping Wan & Colleen McNicholas. (2018) Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users. Obstetrics & Gynecology 132:4, pages 888-894.
Crossref
Crossref
Anna Sansone, Nicoletta De Rosa, Pierluigi Giampaolino, Maurizio Guida, Antonio Simone Laganà & Costantino Di Carlo. (2018) Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Archives of Gynecology and Obstetrics 298:4, pages 731-736.
Crossref
Crossref
Rachael L. Sumner, Rebecca L. McMillan, Alexander D. Shaw, Krish D. Singh, Fred Sundram & Suresh D. Muthukumaraswamy. (2018) Peak visual gamma frequency is modified across the healthy menstrual cycle. Human Brain Mapping 39:8, pages 3187-3202.
Crossref
Crossref
. (2018) ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstetrics & Gynecology 131:5, pages e130-e139.
Crossref
Crossref
. (2017) Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstetrics & Gynecology 130:5, pages e251-e269.
Crossref
Crossref
Stacey Leigh Rubin & Jennifer A. Robinson. (2017) Bleeding Associated with Hormonal Contraceptives: Understanding and Managing a Common Problem. Current Obstetrics and Gynecology Reports 6:3, pages 198-206.
Crossref
Crossref
Rogerio Bonassi Machado, Ilza Maria Urbano Monteiro, Jarbas Magalhães, Cristina Aparecida Falbo Guazzelli, Milena Bastos Brito, Marta Franco Finotti, Jaqueline Neves Lubianca, Luis Carlos Sakamoto & Silvio Antonio Franceschini. (2017) Long-Acting Reversible Contraception. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 39:06, pages 294-308.
Crossref
Crossref
Shandhini Raidoo & Bliss Kaneshiro. (2017) Unscheduled Bleeding on Hormonal Contraceptives: Pathophysiology, Evaluation, and Management Options. Current Obstetrics and Gynecology Reports 6:2, pages 118-125.
Crossref
Crossref
M. K. Findley, E. E. Levi & M. V. Dragoman. (2017) Intrauterine Devices and Contraceptive Implants: Overview of Options and Updates on Method Use. Current Obstetrics and Gynecology Reports 6:2, pages 85-93.
Crossref
Crossref
Rachel E. Zigler & Colleen McNicholas. (2017) Unscheduled vaginal bleeding with progestin-only contraceptive use. American Journal of Obstetrics and Gynecology 216:5, pages 443-450.
Crossref
Crossref
Cynthia Holland-Hall & Elisabeth H. Quint. (2017) Sexuality and Disability in Adolescents. Pediatric Clinics of North America 64:2, pages 435-449.
Crossref
Crossref
Kathryn M. Curtis & Jeffrey F. Peipert. (2017) Long-Acting Reversible Contraception. New England Journal of Medicine 376:5, pages 461-468.
Crossref
Crossref
Katharine B. Simmons, Alison B. Edelman, Rongwei Fu & Jeffrey T. Jensen. (2017) Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial. Contraception 95:2, pages 198-204.
Crossref
Crossref
Jaclyn M. Grentzer, Caitlin Parks & Jeffrey F. Peipert. 2017. Clinical Reproductive Medicine and Surgery. Clinical Reproductive Medicine and Surgery
447
460
.
Jan S. Erkamp & Jérôme Cornette. 2017. Pregnancy and Congenital Heart Disease. Pregnancy and Congenital Heart Disease
23
33
.
Molly J. Richards & Eliza Buyers. (2016) Update on Adolescent Contraception. Advances in Pediatrics 63:1, pages 429-451.
Crossref
Crossref
Allison H. Eliscu & Gale R. Burstein. (2016) Updates in Contraceptive Counseling for Adolescents. The Journal of Pediatrics 175, pages 22-26.e1.
Crossref
Crossref
Kim C Dobromilsky, Penny L Allen, Stephen H Raymond & Bhavna Maindiratta. (2016)
A prospective cohort study of early postpartum etonogestrel implant (Implanon
®
) use and its effect on duration of lochia
. Journal of Family Planning and Reproductive Health Care 42:3, pages 187-193.
Crossref
Crossref
Anna L David & Hannat Akintomide. (2016) Presenting risk information in sexual and reproductive health care. Journal of Family Planning and Reproductive Health Care 42:3, pages 213-219.
Crossref
Crossref
Dan Apter, Paula Briggs, Marjo Tuppurainen, Julia Grunert, Eeva Lukkari-Lax, Sarah Rybowski & Kristina Gemzell-Danielsson. (2016) A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant. Fertility and Sterility 106:1, pages 151-157.e5.
Crossref
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy V. Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2016) Consensus canadien sur la contraception (3e partie de 4) : chapitre 8 – contraception à progestatif seul. Journal of Obstetrics and Gynaecology Canada 38:3, pages 301-326.
Crossref
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2016) Canadian Contraception Consensus (Part 3 of 4): Chapter 8 – Progestin-Only Contraception. Journal of Obstetrics and Gynaecology Canada 38:3, pages 279-300.
Crossref
Crossref
Laura Obijuru, Suzanne Bumpus, Peggy Auinger & Constance D. Baldwin. (2016) Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation. Journal of Adolescent Health 58:3, pages 284-289.
Crossref
Crossref
Quyen Vu, Elizabeth Micks, Erin McCoy & Sarah Prager. (2016) Efficacy and Safety of Long-Acting Reversible Contraception in Women With Cardiovascular Conditions. The American Journal of Cardiology 117:2, pages 302-304.
Crossref
Crossref
Rebecca H. Allen, Andrew M. Kaunitz & Martha Hickey. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
664
693
.
Shandhini Raidoo & Bliss Kaneshiro. (2015) Providing Contraception to Adolescents. Obstetrics and Gynecology Clinics of North America 42:4, pages 631-645.
Crossref
Crossref
EmmaKate Friedlander & Bliss Kaneshiro. (2015) Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception. Obstetrics and Gynecology Clinics of North America 42:4, pages 593-603.
Crossref
Crossref
Jessica W Kiley & Leanne R Griffin. (2015) Contraceptive care after gestational diabetes: considerations for clinical practice. Diabetes Management 5:6, pages 457-472.
Crossref
Crossref
Kathryn J. Lindley, Shayna N. Conner, Alison G. Cahill & Tessa Madden. (2015) Contraception and Pregnancy Planning in Women With Congenital Heart Disease. Current Treatment Options in Cardiovascular Medicine 17:11.
Crossref
Crossref
Maryam Guiahi, Madeline McBride, Jeanelle Sheeder & Stephanie Teal. (2015) Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen. Obstetrics & Gynecology 126:3, pages 508-513.
Crossref
Crossref
Jolien W. Roos-Hesselink, Jerome Cornette, Karen Sliwa, Petronella G. Pieper, Gruschen R. Veldtman & Mark R. Johnson. (2015) Contraception and cardiovascular disease. European Heart Journal 36:27, pages 1728-1734.
Crossref
Crossref
Abbey B. Berenson, Alai Tan & Jacqueline M. Hirth. (2015) Complications and continuation rates associated with 2 types of long-acting contraception. American Journal of Obstetrics and Gynecology 212:6, pages 761.e1-761.e8.
Crossref
Crossref
Atsuko Koyama, David H. Dorfman & Michelle M. Forcier. (2015) Long-Acting Reversible Contraception in the Pediatric Emergency Department. Pediatric Emergency Care 31:4, pages 286-292.
Crossref
Crossref
Amber Truehart & Amy Whitaker. (2015) Contraception for the Adolescent Patient. Obstetrical & Gynecological Survey 70:4, pages 263-273.
Crossref
Crossref
Jennifer Amico, Bhavik Kumar, Hilary Rosenstein & Marji Gold. (2015) The Contraceptive Implant: An Updated Review of the Evidence. Current Obstetrics and Gynecology Reports 4:1, pages 79-88.
Crossref
Crossref
Justin T. Diedrich, Sanyukta Desai, Qiuhong Zhao, Gina Secura, Tessa Madden & Jeffrey F. Peipert. (2015) Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. American Journal of Obstetrics and Gynecology 212:1, pages 50.e1-50.e8.
Crossref
Crossref
Julie Craik & Sam Rowlands. 2015. Medicines For Women. Medicines For Women
227
270
.
Jennifer Salcedo & Aparna Sridhar. 2014. Acute Care and Emergency Gynecology. Acute Care and Emergency Gynecology
126
128
.
. 2014. Acute Care and Emergency Gynecology. Acute Care and Emergency Gynecology
1
158
.
Mary A. Ott, Gina S. Sucato, Paula K. Braverman, William P. Adelman, Elizabeth M. Alderman, Cora C. Breuner, David A. Levine, Arik V. Marcell & Rebecca F. O’Brien. (2014) Contraception for Adolescents. Pediatrics 134:4, pages e1257-e1281.
Crossref
Crossref
Luu Doan Ireland, Vinita Goyal, Christina A. Raker, Anne Murray & Rebecca H. Allen. (2014) The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Contraception 90:3, pages 253-258.
Crossref
Crossref
Roy Jacobstein & Chelsea B. Polis. (2014) Progestin-only contraception: Injectables and implants. Best Practice & Research Clinical Obstetrics & Gynaecology 28:6, pages 795-806.
Crossref
Crossref
Kelli Stidham Hall, Julia R. Steinberg & Sheila M. Marcus. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
69
92
.
Kelli Stidham Hall, Julia R. Steinberg & Sheila M. Marcus. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
69
92
.
Romina L. Barral & Melanie A. Gold. 2014. Contraception for Adolescent and Young Adult Women. Contraception for Adolescent and Young Adult Women
25
44
.
Anitra Beasley & Ann Schutt-Ain?. (2013) Contraceptive Procedures. Obstetrics and Gynecology Clinics of North America 40:4, pages 697-729.
Crossref
Crossref
Lawren D. Wellisch & Julie Chor. (2013) LARC First: What the General Pediatrician Needs to Know about IUDs and Contraceptive Implants. Pediatric Annals 42:9, pages 380-383.
Crossref
Crossref
C. Egarter. (2013) Subdermale kontrazeptive Implantate. Gynäkologische Endokrinologie 11:3, pages 175-183.
Crossref
Crossref
Mary L. Marnach, Margaret E. Long & Petra M. Casey. (2013) Current Issues in Contraception. Mayo Clinic Proceedings 88:3, pages 295-299.
Crossref
Crossref
Petra M. Casey, Margaret E. Long, Mary L. Marnach, Jennifer Fleming-Harvey, Linda B. Drozdowicz & Amy L. Weaver. (2013) Association of body mass index with removal of etonogestrel subdermal implant. Contraception 87:3, pages 370-374.
Crossref
Crossref
M. Hickey & I. S. Fraser. (2012) Iatrogenic unscheduled (breakthrough) endometrial bleeding. Reviews in Endocrine and Metabolic Disorders 13:4, pages 301-308.
Crossref
Crossref
Ellen Mommers, Georges-Fabrice Blum, Thomas G. Gent, Klaus P. Peters, Terje S. Sørdal & Maya Marintcheva-Petrova. (2012) Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. American Journal of Obstetrics and Gynecology 207:5, pages 388.e1-388.e6.
Crossref
Crossref
Hans-Joachim Ahrendt. (2012) Hormonale Optionen jenseits der Pille. gyn?kologie + geburtshilfe 17:4, pages 28-34.
Crossref
Crossref
Brooke Winner, Jeffrey F. Peipert, Qiuhong Zhao, Christina Buckel, Tessa Madden, Jenifer E. Allsworth & Gina M. Secura. (2012) Effectiveness of Long-Acting Reversible Contraception. New England Journal of Medicine 366:21, pages 1998-2007.
Crossref
Crossref
Donald E. Greydanus, Helen D. Pratt & Dilip R. Patel. (2012) Concepts of Contraception for Adolescent and Young Adult Women with Chronic Illness and Disability. Disease-a-Month 58:5, pages 258-320.
Crossref
Crossref
Héloïse Gronier, Geoffroy Robin, Sophie Catteau-Jonard, Charlotte Sonigo & Brigitte Letombe. 2012. Endocrinologie en Gynécologie et Obstétrique. Endocrinologie en Gynécologie et Obstétrique
169
189
.
Cristina A.F. Guazzelli, Flaviano Teixeira de Queiroz, Marcia Barbieri, Fernando A. Barreiros, Maria Regina Torloni & Fabio F. Araujo. (2011) Metabolic effects of contraceptive implants in adolescents. Contraception 84:4, pages 409-412.
Crossref
Crossref
Anne E. Burke. (2011) The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives. American Journal of Obstetrics and Gynecology 205:4, pages S14-S17.
Crossref
Crossref
H.-J. Ahrendt, M. Goeckenjan & T. Rabe. (2011) Neue kontrazeptive VerfahrenModern contraceptive methods. Der Gynäkologe 44:10, pages 827-839.
Crossref
Crossref
Amy Stoddard, Colleen McNicholas & Jeffrey F. Peipert. (2011) Efficacy and Safety of Long-Acting Reversible Contraception. Drugs 71:8, pages 969-980.
Crossref
Crossref
Petra M. Casey, Margaret E. Long, Mary L. Marnach & Jessica E. Bury. (2011) Bleeding related to etonogestrel subdermal implant in a US population. Contraception 83:5, pages 426-430.
Crossref
Crossref
Eve Espey & Tony Ogburn. (2011) Long-Acting Reversible Contraceptives. Obstetrics & Gynecology 117:3, pages 705-719.
Crossref
Crossref
Diana Mansour, Luis Bahamondes, Hilary Critchley, Philip Darney & Ian S. Fraser. (2011) The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users. Contraception 83:3, pages 202-210.
Crossref
Crossref
Amit M. Deokar, Wendy Jackson & Hatim A. Omar. (2011) Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant. International Journal of Adolescent Medicine and Health 23:1.
Crossref
Crossref
P.D. Blumenthal, A. Voedisch & K. Gemzell-Danielsson. (2011) Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Human Reproduction Update 17:1, pages 121-137.
Crossref
Crossref
Martha Hickey & Andrew M. Kaunitz. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
661
687
.
Diana Mansour, Ellen Mommers, Helena Teede, Bjarne Sollie-Eriksen, Oliver Graesslin, Hans-Joachim Ahrendt & Kristina Gemzell-Danielsson. (2010) Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82:3, pages 243-249.
Crossref
Crossref
Cristina Ap. F. Guazzelli, Flaviano Teixeira de Queiroz, Marcia Barbieri, Maria Regina Torloni & Fabio Fernando de Araujo. (2010) Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception 82:3, pages 256-259.
Crossref
Crossref
Berna Dilbaz, Ozlem Ozdegirmenci, Eray Caliskan, Serdar Dilbaz & Ali Haberal. (2010) Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels. Contraception 81:6, pages 510-514.
Crossref
Crossref
Caroline Harvey, Charrlotte Seib & Jayne Lucke. (2009) Continuation rates and reasons for removal among Implanon? users accessing two family planning clinics in Queensland, Australia. Contraception 80:6, pages 527-532.
Crossref
Crossref
E. Weisberg, M. Hickey, D. Palmer, V. O'Connor, L.A. Salamonsen, J.K. Findlay & I.S. Fraser. (2009) A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Human Reproduction 24:8, pages 1852-1861.
Crossref
Crossref
Sarah M.R. Hardman & Ailsa E. Gebbie. (2009) Hormonal contraceptive regimens in the perimenopause. Maturitas 63:3, pages 204-212.
Crossref
Crossref
Kate Adams & Margaret W. Beal. (2009) Implanon: A Review of the Literature With Recommendations for Clinical Management. Journal of Midwifery & Women's Health 54:2, pages 142-149.
Crossref
Crossref